Bicycle Therapeutics bicycletherapeutics.com


Public list: BIO 2016 (619) Pharma Startups (6570) Cancer Therapeutics (1180)

Bicycle Therapeutics (Nasdaq: BCYC) is a clinical-stage biopharmaceutical company developing a class of medicines referred to as Bicycles, for diseases that are underserved by existing therapeutics. Bicycles are fully synthetic short peptides constrained to form two loops that stabilize their structural geometry. This constraint is designed to confer high affinity and selectivity, and the relatively large surface area presented by the molecule allows targets to be drugged that have historically ...Show all

Bicycle Therapeutics (Nasdaq: BCYC) is a clinical-stage biopharmaceutical company developing a class of medicines referred to as Bicycles, for diseases that are underserved by existing therapeutics. Bicycles are fully synthetic short peptides constra...Show all

Company (IPO / Went public)

Phone: +44 (0)1223 497 415

Fax:

B900 Babraham Research Campus

Cambridge, CB22 3AT
England, United Kingdom

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Bicycle Therapeutics $90M May 23, 2019
Barrier Therapeutics $156.2M Aug 20, 2008
See all 14 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Bicycle Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 11 investors

Competitors

Company Status Description Investors
See all 14 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Modulation of structured polypeptide specificity Oct 08, 2012 Oct 13, 2020 Patent
Compounds for treating cancer Jan 05, 2018 Apr 21, 2020 Patent
Bicyclic peptide ligands specific for mt1-mmp Oct 29, 2015 Jan 14, 2020 Patent
Methods for treating cancer Nov 27, 2017 Oct 15, 2019 Patent
Novel polypeptides Oct 28, 2014 May 21, 2019 Patent
See all 17 patents